In this video, Aruna Padmanabhan, MD, discusses the effectiveness of cyclin-dependent kinase inhibitors in the treatment of metastatic hormone-positive breast cancer.
The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 ...
Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health ...
Dr. Waqqas Tai is a cancer doctor who often shares health advice online. He recently revealed what the five most "lethal" ...
The European Commission (EC) has approved sugemalimab in combination with platinum-based chemotherapy for the first-line treatment of patients with metastatic NSCLC with no sensitizing EGFR mutations, ...
TAG24 NEWS on MSN5d
Air pollution fuels lung cancer among non-smokers, reports new medical studyAir pollution is fueling a rise in the most common form of lung cancer among non-smokers, hitting women and people in ...
Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback